Tucatinib

Tucatinib


Tucatinib acts as an HER2 inhibitor, and in BT474 breast carcinoma cells, it effectively suppresses HER2 phosphorylation. Tucatinib inhibits AKT phosphorylation and induces apoptosis in BT474 cells, rendering it a viable cytotoxic agent for formulating antibody-drug conjugates (ADCs).

Molecular structure of the compound BP-40974
    • Unit
    • Price
    • Qty
    • 250 MG
    • $320.00
    • 500 MG
    • $540.00
    • 1 G
    • $850.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire